Advocates in Canada are urging their federal government to invest more in ALS research and trial opportunities.

ALS patients seem to have immune cells that attack the C9ORF72 protein in nerve cells, suggesting ALS may be an autoimmune ...

Northwestern University professor Hande Ozdinler is hoping to change how ALS is treated, saying the disease is too complex ...

FGF21, a hormone that helps cells regulate energy use and respond to stress, may protect muscles and nerve cells from damage ...

Researchers identified three subtypes of amyotrophic lateral sclerosis, each with distinct mechanisms that could be future ...

Faced with a rapidly progressing form of ALS, Iomar Barrett describes the disease trajectory that's less common on social ...

Immune checkpoint proteins — proteins that help regulate immune response — were elevated on T-cells and in the blood of ...

Patient enrollment is complete for a Phase 2b/3 clinical trial evaluating MN-166 (ibudilast) for ALS, developer % Medicinova ...

Iomar Barrett was diagnosed with ALS in April 2024. His current focus is bringing a novel gene therapy to those with sporadic ...

A conversation during a long walk with an old friend reminds columnist Kristin Neva that life is fragile and precious.

For columnist Juliet Taylor, fall brings back vivid memories of the October when her late husband, Jeff, was diagnosed with ...

A new trial assessing the ability of COYA 302 to slow the progression of ALS will enroll up to 120 patients at sites in the U ...